Guided Therapeutics Inc GTHP
We take great care to ensure that the data presented and summarized in this overview for GUIDED THERAPEUTICS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in GTHP
Top Purchases
Top Sells
About GTHP
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Insider Transactions at GTHP
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2024
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
36,161
+0.51%
|
-
|
|
Oct 14
2024
|
Richard P. Blumberg |
BUY
Other acquisition or disposition
|
Direct |
400,000
+5.64%
|
-
|
|
Sep 23
2024
|
John E Imhoff |
BUY
Open market or private purchase
|
Direct |
1,666,667
+19.06%
|
-
|
|
Aug 21
2024
|
Alan Grujic |
BUY
Other acquisition or disposition
|
Direct |
36,602
+2.47%
|
-
|
|
Aug 21
2024
|
Richard P. Blumberg |
BUY
Other acquisition or disposition
|
Direct |
170,563
+2.64%
|
-
|
|
Aug 21
2024
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
183,008
+3.27%
|
-
|
|
Jul 15
2024
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
48,327
+0.92%
|
-
|
|
Apr 05
2024
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
48,638
+0.93%
|
-
|
|
Mar 26
2024
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
4,420
+0.09%
|
-
|
|
Mar 26
2024
|
Richard P. Blumberg |
BUY
Other acquisition or disposition
|
Direct |
153,805
+1.24%
|
-
|
|
Mar 01
2024
|
Richard P. Blumberg |
BUY
Other acquisition or disposition
|
Direct |
400,000
+6.28%
|
-
|
|
Jan 16
2024
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
37,324
+0.72%
|
-
|
|
Dec 01
2023
|
Richard P. Blumberg |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1,642,500
+22.79%
|
-
|
|
Oct 16
2023
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
37,410
+0.73%
|
-
|
|
Sep 01
2023
|
Richard P. Blumberg |
BUY
Other acquisition or disposition
|
Direct |
400,000
+9.25%
|
-
|
|
Aug 21
2023
|
Richard P. Blumberg |
BUY
Other acquisition or disposition
|
Indirect |
104,914
+2.89%
|
-
|
|
Aug 21
2023
|
Alan Grujic |
BUY
Other acquisition or disposition
|
Direct |
22,514
+1.57%
|
-
|
|
Aug 21
2023
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
112,568
+2.18%
|
-
|
|
Aug 11
2023
|
John E Imhoff |
BUY
Open market or private purchase
|
Direct |
500,899
+9.21%
|
-
|
|
Jul 17
2023
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
26,301
+0.59%
|
-
|
Last 12 Months Summary
| Other acquisition or disposition | 1.52M shares |
|---|---|
| Open market or private purchase | 1.67M shares |
| Exercise of in-the-money or at-the-money derivatives securities | 1.64M shares |